Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: Maricel Apuli, officer

Transaction date: July 30, 2026

Reporting date: Aug. 3, 2026

Average share price: 80.06

Sold 2000.0 shares for 160120.0